Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Oncotarget|September 30, 2015
The pan-HER family tyrosine kinase inhibitor afatinib overcomes HER3 ligand heregulin-mediated resistance to EGFR inhibitors in non-small cell lung cancerKimio Yonesaka, Keita Kudo, Satomi Nishida, et al.
Oncogene|October 11, 2018
An HER3-targeting antibody-drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLCKimio Yonesaka, Naoki Takegawa, Satomi Watanabe, et al.
Plos One|November 17, 2015
Combined Analysis of Plasma Amphiregulin and Heregulin Predicts Response to Cetuximab in Metastatic Colorectal CancerKimio Yonesaka, Naoki Takegawa, Taroh Satoh, et al.
Cancer Science|November 4, 2018
Mutational activation of the epidermal growth factor receptor down-regulates major histocompatibility complex class I expression via the extracellular signal-regulated kinase in non-small cell lung cancerSatomi Watanabe, Hidetoshi Hayashi, Koji Haratani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2021
KRAS Inhibitor Resistance in <i>MET</i>-Amplified <i>KRAS</i> <sup>G12C</sup> Non-Small Cell Lung Cancer Induced By RAS- and Non-RAS-Mediated Cell Signaling MechanismsShinichiro Suzuki, Kimio Yonesaka, Takeshi Teramura, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 25, 2017
Peripheral Blood Biomarkers Associated with Clinical Outcome in Non-Small Cell Lung Cancer Patients Treated with NivolumabJunko Tanizaki, Koji Haratani, Hidetoshi Hayashi, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2022
Mechanisms of primary and acquired resistance to immune checkpoint inhibitors in advanced non-small cell lung cancer: A multiplex immunohistochemistry-based single-cell analysisKohsuke Isomoto, Koji Haratani, Takahiro Tsujikawa, et al.
Thoracic Cancer|December 10, 2022
Successful treatment with atezolizumab combination chemotherapy in a patient with high-grade fetal adenocarcinoma of the lung: A case reportKana Fujimoto, Satomi Watanabe, Yuto Yasuda, et al.
The Journal of Clinical Investigation|March 10, 2026
Spatial single-cell proteotyping reveals immunotherapy-resistant features within the complex tumor microenvironment of metastatic NSCLCKohsuke Isomoto, Koji Haratani, Takahiro Tsujikawa, et al.
International Journal of Clinical Oncology|June 12, 2021
CAPP-seq analysis of circulating tumor DNA from patients with EGFR T790M-positive lung cancer after osimertinibRyoji Kato, Hidetoshi Hayashi, Kazuko Sakai, et al.
Pageof 7